Migraine features in Neurological Foundation’s Headlines magazine
Migraine disease and Migraine Foundation Aotearoa New Zealand featured in the Neurological Foundation’s Autumn 2025 Headlines magazine. The feature article: A new era in migraine treatments, focuses predominantly on the CGRP monoclonal antibody medications for migraine, through discussions with Professor Peter Goadsby and Professor Debbie Hay during our Migraine Unravelled event on 30 November 2024. […]
Highlights from day one of the Migraine World Summit 2025
It’s the first day of the Migraine World Summit – we’ve listened to two of the interviews available free to watch today. Check out the highlights below and sign up to listen to these and more over the coming week. The latest insights on CGRP-targeted medications in migraine treatment (Dr Amaal Starling) This interview gives […]
Migraine research funding success
We’re delighted to announce that Dr Fiona Imlach, one of the co-founders of Migraine Foundation Aotearoa New Zealand, has been successful in receiving a grant from the Health Research Council. This will fund work to scope out how we could undertake a cost-of-illness study in Aotearoa New Zealand and estimate how much migraine costs the […]
Unanswered questions about the use of Botoxᵀᴹ for chronic migraine
Onabotulinum toxinA (commonly known by its trade name Botoxᵀᴹ) is an effective treatment for chronic migraine (when headache occurs for 15 days or more a month for at least three months). Botoxᵀᴹ is famous for erasing unwanted facial wrinkles and its inclusion in the arsenal against chronic migraine was serendipitous. People with migraine who were […]
Variations in neurology referrals around the country
We’re always interested in finding out more about how people with migraine can access health care services, and what, where and when there are difficulties. Last year, we put in an Official Information Act request to Te Whatu Ora/Health New Zealand, to see if we could find out how many people were seen by neurologists […]
GPs hear about migraine research at Wellington conference
Migraine disease was on the programme of the GP24 Conference in Wellington on 27th July. This is the annual conference of the Royal New Zealand College of General Practitioners, which is regularly attended by hundreds of GPs and provides valued continuing medication education credits. Our summer student Blair McInnernay presented at the conference, giving an […]
Large unmet need for effective migraine treatment in New Zealand
Press release Many people with migraine in New Zealand are not receiving best-practice management, according to research published today in the New Zealand Medical Journal using results from a survey of 530 people with migraine run by Migraine Foundation Aotearoa New Zealand. The lack of best-practice management occurred with both treating and preventing migraine attacks.“Prompt […]
Update on the number of people with migraine in New Zealand
In the absence of up-to-date national statistics on migraine in Aotearoa New Zealand, we rely on estimates from the Global Burden of Disease (GBD) study. This is an international research project that draws on data from around the world to estimate and compare the prevalence, mortality and disability impact of a large range of diseases, […]
Multiple barriers to health care for migraine disease
Press release People with migraine disease experience similar barriers to health care as patients with other conditions, but these are compounded by stigma and lack of access to modern treatments. These were findings of research published in the Journal of Primary Health Care, based on a survey of 530 people with migraine from Migraine Foundation […]
Survey results published in NZ Medical Journal
We published our first paper from the inaugural Migraine in Aotearoa New Zealand Survey in the NZ Medical Journal on Friday 22 March. This explored the impact of living with migraine in Aotearoa New Zealand From the media release sent out from the University of Otago, survey respondents reported significant disability, with half being unable […]
